Global TB Diagnostic Market 2015-2019

結核(TB)診断の世界市場2015-2019

◆タイトル:Global TB Diagnostic Market 2015-2019
◆商品コード:IRTNTR6506
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2015年7月22日
◆ページ数:82
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、結核(TB)診断の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、結核(TB)診断の世界市場規模及び予測、パイプライン動向、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About TB Diagnostics
TB is an infectious bacterial disease caused by Mycobacterium tuberculosis. It is communicable and can be transmitted from one person to another. TB is one of the world’s deadliest communicable diseases. In 2013, there were 9 million new TB cases and 1.5 million TB deaths, out of which 1.1 million among HIV-negative people and 0.4 million among HIV-positive people.

The symptoms of active TB of the lung include coughing, occasionally with sputum or blood, weakness, chest pains, weight loss, fever, and night sweats. Though the disease is preventive in developed countries, there is a shortage of efficient diagnosis tools and detection in developing countries.

Technavio’s analysts forecast the global TB diagnostic market to grow at a CAGR of 2.97% during the period 2014-2019.

[Covered in this Report]
The report covers the present scenario and the growth prospects of the global TB diagnostic market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales of TB diagnostic products in the market.

Technavio’s report, Global TB Diagnostic Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the global TB diagnostics market landscape and its growth prospects over the coming years. The report includes a discussion of the key vendors operating in this market.

[Key Geographies]
• Americas
• APAC
• EMEA

[Key Vendors]
• Abbott
• Alere
• Becton, Dickinson
• F. Hoffmann-La Roche

[Other Prominent Vendors]
• Siemens
• BioMérieux
• Cepheid
• Hain Lifescience
• Hologic
• Ortho Clinical
• Epistem UK
• Eiken Chemical Japan
• Alere US

[Market Driver]
• High Prevalence of TB
• For a full, detailed list, view our report

[Market Challenge]
• Insensitivity of Spear Microscopy
• For a full, detailed list, view our report

[Market Trend]
• Intensification of Rapid Tests in Developing Countries
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07.Prevalence and Incidence Rate

08.Advances in Technology
08.1 Second-generation Nucleic Acid Detection
08.2 Next-generation Nucleic Acid Detection

09.TB Diagnostics Pipeline

10.Market Segmentation by Disease Stage
10.1 Global Latent TB Diagnostics Market
10.2 Global Active TB Diagnostics Market
10.3 Global Drug Susceptibility Tests Market

11.Geographical Segmentation
11.1 Global TB Diagnostics Market in APAC
11.1.1 India
11.2 Global TB Diagnostics Market in Americas
11.2.1 Brazil
11.3 Global TB Diagnostics Market in EMEA
11.3.1 South Africa

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and Their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and Their Impact

19.Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Market Share Analysis 2013
19.2.1 Abbott Diagnostics
19.2.2 Alere
19.2.3 BD
19.2.4 Roche Diagnostics
19.3 Other Prominent Vendors

20.Key Vendor Analysis
20.1 Abbott Diagnostics
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Geographical Presence
20.1.4 SWOT Analysis
20.2 Alere
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Business Segmentation by Revenue 2013
20.2.4 Business Segmentation by Revenue 2012 and 2013
20.2.5 Geographical Segmentation by Revenue 2013
20.2.6 Business Strategy
20.2.7 Recent Developments
20.2.8 SWOT Analysis
20.3 BD
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Business Segmentation
20.3.4 Revenue Segmentation by Business
20.3.5 Segmental Revenue Comparison 2013 and 2012
20.3.6 Revenue Segmentation by Geography
20.3.7 Business Strategy
20.3.8 Key Developments
20.3.9 SWOT Analysis
20.4 Roche Diagnostics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation by Revenue 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis

21.Other Reports in This Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global TB Diagnostics Market 2014-2019 ($ millions)
Exhibit 3: Incidence Rate per 100,000 Individuals 2013
Exhibit 4: High-burden Countries
Exhibit 5: Product Pipeline: TB Diagnostics
Exhibit 6: Segmentation of Global Active TB Diagnostics Market 2014
Exhibit 7: Segmentation of Global TB Diagnostics Market by Disease Stage 2014
Exhibit 8: Segmentation of Global TB Diagnostics Market by Geography 2014
Exhibit 9: India: Revenue Segmentation by Entity 2012
Exhibit 10: Public Sector: Segmentation of TB Diagnostics by Revenue 2012
Exhibit 11: Private Sector: Segmentation of TB Diagnostics by Revenue 2012
Exhibit 12: Brazil: Revenue Segmentation by Entity 2012
Exhibit 13: Brazil: Common TB Diagnostic Tests and Their Cost 2012
Exhibit 14: Brazil: Segmentation of TB Diagnostic Tests by Revenue 2012-2013
Exhibit 15: South Africa: Revenue Segmentation of TB Diagnostic Tests by Entity 2012-2013
Exhibit 16: Diagnostic Tests and Costs by Sectors
Exhibit 17: South Africa: Segmentation of TB by Revenue 2012-2013
Exhibit 18: South Africa: Volume of Tests in Public Sector 2012-2013
Exhibit 19: South Africa: Volume of Tests in Private Sector 2012-2013
Exhibit 20: Key Takeaways: Abbott Diagnostics
Exhibit 21: Key Takeaways: Alere
Exhibit 22: Key Takeaways: BD
Exhibit 23: Key Takeaways: Roche Diagnostics
Exhibit 24: Abbott Diagnostics: Geographical Presence
Exhibit 25: Alere: Business Segmentation by Revenue 2013
Exhibit 26: Alere: Business Segmentation by Revenue 2012 and 2013 ($ billions)
Exhibit 27: Alere: Geographical Segmentation by Revenue 2013
Exhibit 28: Product Categorization of BD
Exhibit 29: Revenue Segmentation of BD 2013
Exhibit 30: Revenue Comparison ($ millions)
Exhibit 31: Revenue Segmentation of BD by Geography 2013
Exhibit 32: Roche Diagnostics: Business Segmentation by Revenue 2014
Exhibit 33: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billions)
Exhibit 34: Roche Diagnostics: Geographical Segmentation by Revenue 2014



【掲載企業】

Abbott, Alere, Becton, Dickinson, F. Hoffmann-La Roche, Siemens, BioMérieux, Cepheid, Hain Lifescience, Hologic, Ortho Clinical, Epistem UK, Eiken Chemical Japan, Alere US

【資料のキーワード】

結核(TB)、結核診断、結核検査、核酸、医薬品、製品パイプライン

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[結核(TB)診断の世界市場2015-2019] (Global TB Diagnostic Market 2015-2019 / IRTNTR6506)販売に関する免責事項
[結核(TB)診断の世界市場2015-2019] (Global TB Diagnostic Market 2015-2019 / IRTNTR6506)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆